| Mylan Pharma GmbH - Trilipix 135 mg, Retardkapseln |
| 61433 | | 02 | | Trilipix 135 mg | | Retardkapseln | | C10AB11 | | Choline Fenofibrate | | 17.07.2012 | | |
|
| Composition |
| acidum fenofibratum 135 mg ut cholini fenofibratum, color.: E 132, excipiens pro capsula. |
| Packungsbestandteile |
| Delayed release capsules | | | | | | Active Agent | Dose |
|---|
| Acidum Fenofibratum | 135 mg correspond Cholini Fenofibratum |
| | | | Inactive agents | | additional_information |
|---|
| E 132 | | color. |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 30 Capsule(s) | PR | PR | B | | Yes |
|
